If you made any changes in Pure these will be visible here soon.

Personal profile


My research focus is on preeclampsia. Based on findings from protein- and gene array studies, free fetal hemoglobin has been shown to be a potential new predictive- and diagnostic marker for preeclampsia. We are now focusing on a new potential treatment for preeclampsia based on a free hemoglobin scavenger, alpha-1-microglobulin (A1M).

Societal impact

Free fetal hemoglobin as a potential new predictive- and diagnostic marker for preeclampsia is further developed in a biotech company, Preelumina Diagnostics, that I am cofounder of. I am also cofunder of A1M Pharma, a company that is developing a new potential therapeutic drug for preeclampsia.

UKÄ subject classification

  • Obstetrics, Gynecology and Reproductive Medicine

Free keywords

  • Preeclampsia
  • free fetal hemoglobin
  • alpha-1-microglubin


Dive into the research topics where Stefan Hansson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or